BananaIP Counsels Logo

Celebrating 20 Years of IP Excellence

Image for From Dress Pin to Safety Pin

From Dress Pin to Safety Pin

This post was first published on 2nd September, 2014. Inventive step / Non-Obviousness is one of the most important patentability criteria in almost all patent jurisdictions. Non-obviousness is the term used by the USPTO and is codified in 35 USC § 103. The requirement is that the claimed invention being patented should not be obvious, meaning that a "person having ordinary skill in the art" should not be able to easily guess or put two or more things together to arrive at the invention seeking a…
July 2, 2019 Intellectual Property, Patents 0Comment 1438Views 0Like
Share

Read more

The featured image is the logo of novartis.

Patentability and Section 3(d), History of Patent Law in India, Patentability of Imatinib Masylate in Beta Crystalline Form – Novartis Case Abridged by Dr. Kalyan C. Kankanala

This abridged version of the Novartis case was used by Dr. Kalyan C. Kankanala to explain to the students of UPES, the patentability requirements under the Patent Law and the significance of Section 3(d) under the Patents Act. This abridged document was provided to the B.tech - LLB students at UPES School of Law as part of the Patent Law and Practice Program being taught by the BananaIP Team. The Novartis case has been abridged to suit the discussion in the class, and to…
October 31, 2017 Intellectual Property, Patents 0Comment 556Views 0Like
Share

Read more

The featured image is a screen shot of the first slide that forms part of this presentation.

Analyzing Patentability of Inventions – A Presentation by Dr. Kalyan C. Kankanala at the UPES School of Law

This presentation is part of the 'Patent Law and Practice Program' being taught by BananaIP Team at UPES School of Law to B.tech-LLB Students. This presentation is titled "Analyzing Patentability of Inventions" and covers the following topics: Patentability Requirements Patentable Subject Matter Exclusions Examples Industrial applicability Novelty Inventive Step Secondary Indication Examples Specification Dr. Kalyan's Latest IP Thriller - The Dravidian You may access the full presentation here: About Dr. Kalyan…
October 31, 2017 Intellectual Property, Patents 0Comment 531Views 0Like
Share

Read more

The featured image shows the word patent written in blue on a white background. The post is about the latest Patent updates. To know more, please click here.

Patent News

  Hello Readers!! There has been a lot that has been brewing over the past few weeks with respect to Patents. We have decided to recapitulate the patent news which have recently hit the headlines in our segment, Weekly Trends. Let us take a quick look at what happened in the past weeks, with this weekly update.   Dyson is coming to India! Dyson Ltd. a well-established UK-based Technology company will be entering India with its wide range of patented products next year…
November 22, 2016 Intellectual Property, Patents 0Comment 528Views 0Like
Share

Read more

Intellepedia - IP News Updates

Patent Law in India- PPT on Patentability Requirements by Dr. Kalyan C. Kankanala at NLSIU

This presentation was delivered by Dr. Kalyan C. Kankanala at NLSIU, Bangalore, India, as a part of the Patent law course offered for PGDIP students. The presentation covers: Introduction to Patentability Requirements and their role in the Patent System in India; The Patent Filter Model; Patentable Subject Matter - Eligible Subjects and Ineligible Subjects; Inventions and Non-Patentable Subject Matter; Section 3 Exclusions with special reference to Section 3(d); Novartis Case - New Form, Known…
October 18, 2015 Patents 0Comment 1045Views 0Like
Share

Read more

pharmaceutical patent x

Merck v. Glenmark – A Bitter Battle of Pills

  The Delhi High Court has restrained Glenmark from making and marketing generic versions of Merck Sharp & Dohme (MSD)'s popular antidiabetic drug “Januvia” (sitagliptin) and “Janumet” (combination of sitagliptin and metformin) in its latest order dated October 7, 2015. The order restrains Glenmark from making, using, selling, distributing, advertising, exporting, offering for sale or dealing in Sitagliptin Phosphate Monohydrate or any other salt of Sitagliptin in any form, alone or in combination with one or more other drugs or from…
October 9, 2015 Intellectual Property 0Comment 3644Views 0Like
Share

Read more

Special Report

Special 301 Report: Chapter V. Inventive Step & 3(d) – Comprehending Apprehension or Apprehending Comprehension?

Is Section 3(d) an extension of the Inventive Step analysis? The answer to this question can make a difference to the compliance of non-discrimination obligations under the TRIPs Agreement, and so it plays a significant part. Article 27.1 of the TRIPs Agreement reads as follows: Subject to the provisions of paragraphs 2 and 3, patents shall be available for any inventions, whether products or processes, in all fields of technology, provided that they are new, involve an inventive step and are capable…
June 15, 2014 Intellectual Property, Patents 0Comment 531Views 0Like
Share

Read more